Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinial Trials

Silence Therapeutics appoints Dr Annalisa Jenkins as non-executive chair

The Dimension Therapeutics CEO succeeds Dr Stephen Parker, who becomes a non-executive director

- PMLiVE

MC Services welcomes Dr Claudia Gutjahr-Loeser to its management team

She joins the PR firm from MorphoSys, where she was senior VP

- PMLiVE

Positive disruption in business intelligence

A drug launch strategy

- PMLiVE

Change in the pharma industry is inevitable

But successul change isn't

- PMLiVE

AZ gets US green light for new Bydureon formulation

Its latest injectable suspension proven to reduce blood sugar levels

Novartis Gehry Building

Alcon spin-out more likely but not imminent, says Novartis

A stand-alone company could offer “additional shareholder value”

- PMLiVE

TiGenix’s Crohn’s fistulas treatment wins orphan drug status

FDA designation follows positive trial results

- PMLiVE

Patient disengagement

Understanding the why

Incanthera appoints Laura Brogden as CFO

She joins from Summ.it

- PMLiVE

PharmaLex strengthens international team

Consultancy group appoints Adrian Pencak

National Institute for Health and Care Excellence NICE logo

NICE backs GSK’s ‘bubble baby’ gene therapy

Strimvelis will treat children under the NHS for immunodeficiency

- PMLiVE

Meetings

Ensuring a box office success

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links